Demegillo, NiƱa Felyn .
HRN: 26-87-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2025
AMPICILLIN 1GM (VIAL)
03/24/2025
03/30/2025
IV
2g
Q6
G2P0(0010) PU 39 1/7 Weeks APG By LMP; Cephalic In Latent Phase Of Labor; PROM X 6 Days
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes